COPD Exacerbation Follow Up — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COPD Exacerbation Follow Up — Stella

Home/COPD (Chronic Obstructive Pulmonary Disease)/

View on ClinicalTrials.gov

Recruiting

Back to COPD (Chronic Obstructive Pulmonary Disease) trials

Trial locations(2 sites)

United States

Cooper University Health Care, Cherry Hill, New Jersey

Thomas Jefferson University, Philadelphia, Pennsylvania

Key details

Sponsor

Viz.ai, Inc.

Collaborators

Sanofi

Enrollment target

~485 participants

Started

February 2026

Primary completion

July 2027

Age range

40 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.